Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Aug 14, 2024 7:47am
95 Views
Post# 36178036

RE:RE:Q2 Results

RE:RE:Q2 Results
Macpoor wrote: Rom was not a day! Building a business takes time. Think about Amazon, 3o years ago was a tiny company but today is a different ballgame. So LABS has products and there are demands for it. 


LABS is becoming an ever-decreasing small voice in an ever-increasing large choir.

Other are growing at double digits and are actually penetrating in the global markets that LABS apparently has 'strong partnerships' in.  If LABS can't grow in those jurisdictions, with the partners they have, the competition won't stop growing and there is only so much share to go around.

The time for explosive growth is now, the time to be a strong market participanrt is now.  Nothing in the release suggests that LABS is capable of either.  Pidduck obviously is a M&A guy through and through and wants inorganic growth.  That is a most unfortunate path forward when you don't have any real money in the bank and the shares O/S totals over 400M.
<< Previous
Bullboard Posts
Next >>